3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Liver Neoplasms
1
Glioma
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Advanced Breast Cancer
1
Interventions
mogamulizumab
4
Specimen Handling
3
Immunoglobulin G
3
Disulfides
3
Cyclophosphamide
3
Biopsy
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Tacrolimus
2
Photopheresis
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Busulfan
2
Blood Specimen Collection
2
talimogene laherparepvec
1
magrolimab
1
duvelisib
1
durvalumab
1
Vincristine
1
Valganciclovir
1
Urine Specimen Collection
1
Transplantation
1
Therapeutics
1
Sirolimus
1
Radiotherapy
1
Prednisone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sezary Syndrome
×
Ritonavir
×
1 year
×
Clear all
No trials found.